Global Cholera Vaccine (Oral Route) Market Growth 2022-2028
- LP 4864180
- 71 Pages
- February 2022
- Pharmaceuticals
The United States Cholera Vaccine (Oral Route) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cholera Vaccine (Oral Route) market, reaching US$ million by the year 2028. As for the Europe Cholera Vaccine (Oral Route) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cholera Vaccine (Oral Route) players cover PaxVax, Sanofi, Valneva, and EuBiologics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cholera Vaccine (Oral Route) market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Shanchol
Dukoral
Vaxchora
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
PaxVax
Sanofi
Valneva
EuBiologics
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cholera Vaccine (Oral Route) Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Cholera Vaccine (Oral Route) by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Cholera Vaccine (Oral Route) by Country/Region, 2017, 2022 & 2028
2.2 Cholera Vaccine (Oral Route) Segment by Type
2.2.1 Shanchol
2.2.2 Dukoral
2.2.3 Vaxchora
2.2.4 Others
2.3 Cholera Vaccine (Oral Route) Sales by Type
2.3.1 Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2022)
2.3.2 Global Cholera Vaccine (Oral Route) Revenue and Market Share by Type (2017-2022)
2.3.3 Global Cholera Vaccine (Oral Route) Sale Price by Type (2017-2022)
2.4 Cholera Vaccine (Oral Route) Segment by Application
2.4.1 Hospital
2.4.2 Research & Academic Laboratories
2.4.3 Pharmaceutical & Biotechnology Companies
2.4.4 Others
2.5 Cholera Vaccine (Oral Route) Sales by Application
2.5.1 Global Cholera Vaccine (Oral Route) Sale Market Share by Application (2017-2022)
2.5.2 Global Cholera Vaccine (Oral Route) Revenue and Market Share by Application (2017-2022)
2.5.3 Global Cholera Vaccine (Oral Route) Sale Price by Application (2017-2022)
3 Global Cholera Vaccine (Oral Route) by Company
3.1 Global Cholera Vaccine (Oral Route) Breakdown Data by Company
3.1.1 Global Cholera Vaccine (Oral Route) Annual Sales by Company (2020-2022)
3.1.2 Global Cholera Vaccine (Oral Route) Sales Market Share by Company (2020-2022)
3.2 Global Cholera Vaccine (Oral Route) Annual Revenue by Company (2020-2022)
3.2.1 Global Cholera Vaccine (Oral Route) Revenue by Company (2020-2022)
3.2.2 Global Cholera Vaccine (Oral Route) Revenue Market Share by Company (2020-2022)
3.3 Global Cholera Vaccine (Oral Route) Sale Price by Company
3.4 Key Manufacturers Cholera Vaccine (Oral Route) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Cholera Vaccine (Oral Route) Product Location Distribution
3.4.2 Players Cholera Vaccine (Oral Route) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Cholera Vaccine (Oral Route) by Geographic Region
4.1 World Historic Cholera Vaccine (Oral Route) Market Size by Geographic Region (2017-2022)
4.1.1 Global Cholera Vaccine (Oral Route) Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Cholera Vaccine (Oral Route) Annual Revenue by Geographic Region
4.2 World Historic Cholera Vaccine (Oral Route) Market Size by Country/Region (2017-2022)
4.2.1 Global Cholera Vaccine (Oral Route) Annual Sales by Country/Region (2017-2022)
4.2.2 Global Cholera Vaccine (Oral Route) Annual Revenue by Country/Region
4.3 Americas Cholera Vaccine (Oral Route) Sales Growth
4.4 APAC Cholera Vaccine (Oral Route) Sales Growth
4.5 Europe Cholera Vaccine (Oral Route) Sales Growth
4.6 Middle East & Africa Cholera Vaccine (Oral Route) Sales Growth
5 Americas
5.1 Americas Cholera Vaccine (Oral Route) Sales by Country
5.1.1 Americas Cholera Vaccine (Oral Route) Sales by Country (2017-2022)
5.1.2 Americas Cholera Vaccine (Oral Route) Revenue by Country (2017-2022)
5.2 Americas Cholera Vaccine (Oral Route) Sales by Type
5.3 Americas Cholera Vaccine (Oral Route) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cholera Vaccine (Oral Route) Sales by Region
6.1.1 APAC Cholera Vaccine (Oral Route) Sales by Region (2017-2022)
6.1.2 APAC Cholera Vaccine (Oral Route) Revenue by Region (2017-2022)
6.2 APAC Cholera Vaccine (Oral Route) Sales by Type
6.3 APAC Cholera Vaccine (Oral Route) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Cholera Vaccine (Oral Route) by Country
7.1.1 Europe Cholera Vaccine (Oral Route) Sales by Country (2017-2022)
7.1.2 Europe Cholera Vaccine (Oral Route) Revenue by Country (2017-2022)
7.2 Europe Cholera Vaccine (Oral Route) Sales by Type
7.3 Europe Cholera Vaccine (Oral Route) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cholera Vaccine (Oral Route) by Country
8.1.1 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Country (2017-2022)
8.1.2 Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Country (2017-2022)
8.2 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type
8.3 Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Cholera Vaccine (Oral Route)
10.3 Manufacturing Process Analysis of Cholera Vaccine (Oral Route)
10.4 Industry Chain Structure of Cholera Vaccine (Oral Route)
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Cholera Vaccine (Oral Route) Distributors
11.3 Cholera Vaccine (Oral Route) Customer
12 World Forecast Review for Cholera Vaccine (Oral Route) by Geographic Region
12.1 Global Cholera Vaccine (Oral Route) Market Size Forecast by Region
12.1.1 Global Cholera Vaccine (Oral Route) Forecast by Region (2023-2028)
12.1.2 Global Cholera Vaccine (Oral Route) Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Cholera Vaccine (Oral Route) Forecast by Type
12.7 Global Cholera Vaccine (Oral Route) Forecast by Application
13 Key Players Analysis
13.1 PaxVax
13.1.1 PaxVax Company Information
13.1.2 PaxVax Cholera Vaccine (Oral Route) Product Offered
13.1.3 PaxVax Cholera Vaccine (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 PaxVax Main Business Overview
13.1.5 PaxVax Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Cholera Vaccine (Oral Route) Product Offered
13.2.3 Sanofi Cholera Vaccine (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Valneva
13.3.1 Valneva Company Information
13.3.2 Valneva Cholera Vaccine (Oral Route) Product Offered
13.3.3 Valneva Cholera Vaccine (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Valneva Main Business Overview
13.3.5 Valneva Latest Developments
13.4 EuBiologics
13.4.1 EuBiologics Company Information
13.4.2 EuBiologics Cholera Vaccine (Oral Route) Product Offered
13.4.3 EuBiologics Cholera Vaccine (Oral Route) Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 EuBiologics Main Business Overview
13.4.5 EuBiologics Latest Developments
14 Research Findings and Conclusion
Table 1. Cholera Vaccine (Oral Route) Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Cholera Vaccine (Oral Route) Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Shanchol
Table 4. Major Players of Dukoral
Table 5. Major Players of Vaxchora
Table 6. Major Players of Others
Table 7. Global Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 8. Global Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2022)
Table 9. Global Cholera Vaccine (Oral Route) Revenue by Type (2017-2022) & ($ million)
Table 10. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2017-2022)
Table 11. Global Cholera Vaccine (Oral Route) Sale Price by Type (2017-2022) & (USD/Unit)
Table 12. Global Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 13. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2022)
Table 14. Global Cholera Vaccine (Oral Route) Revenue by Application (2017-2022)
Table 15. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application (2017-2022)
Table 16. Global Cholera Vaccine (Oral Route) Sale Price by Application (2017-2022) & (USD/Unit)
Table 17. Global Cholera Vaccine (Oral Route) Sales by Company (2020-2022) & (K Units)
Table 18. Global Cholera Vaccine (Oral Route) Sales Market Share by Company (2020-2022)
Table 19. Global Cholera Vaccine (Oral Route) Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Cholera Vaccine (Oral Route) Revenue Market Share by Company (2020-2022)
Table 21. Global Cholera Vaccine (Oral Route) Sale Price by Company (2020-2022) & (USD/Unit)
Table 22. Key Manufacturers Cholera Vaccine (Oral Route) Producing Area Distribution and Sales Area
Table 23. Players Cholera Vaccine (Oral Route) Products Offered
Table 24. Cholera Vaccine (Oral Route) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Cholera Vaccine (Oral Route) Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Cholera Vaccine (Oral Route) Sales Market Share Geographic Region (2017-2022)
Table 29. Global Cholera Vaccine (Oral Route) Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Cholera Vaccine (Oral Route) Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Cholera Vaccine (Oral Route) Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Cholera Vaccine (Oral Route) Sales Market Share by Country/Region (2017-2022)
Table 33. Global Cholera Vaccine (Oral Route) Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Cholera Vaccine (Oral Route) Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Cholera Vaccine (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 36. Americas Cholera Vaccine (Oral Route) Sales Market Share by Country (2017-2022)
Table 37. Americas Cholera Vaccine (Oral Route) Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Cholera Vaccine (Oral Route) Revenue Market Share by Country (2017-2022)
Table 39. Americas Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 40. Americas Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2022)
Table 41. Americas Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 42. Americas Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2022)
Table 43. APAC Cholera Vaccine (Oral Route) Sales by Region (2017-2022) & (K Units)
Table 44. APAC Cholera Vaccine (Oral Route) Sales Market Share by Region (2017-2022)
Table 45. APAC Cholera Vaccine (Oral Route) Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Cholera Vaccine (Oral Route) Revenue Market Share by Region (2017-2022)
Table 47. APAC Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 48. APAC Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2022)
Table 49. APAC Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 50. APAC Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2022)
Table 51. Europe Cholera Vaccine (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 52. Europe Cholera Vaccine (Oral Route) Sales Market Share by Country (2017-2022)
Table 53. Europe Cholera Vaccine (Oral Route) Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Cholera Vaccine (Oral Route) Revenue Market Share by Country (2017-2022)
Table 55. Europe Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 56. Europe Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2022)
Table 57. Europe Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 58. Europe Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Cholera Vaccine (Oral Route) Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Cholera Vaccine (Oral Route) Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Cholera Vaccine (Oral Route) Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Cholera Vaccine (Oral Route)
Table 68. Key Market Challenges & Risks of Cholera Vaccine (Oral Route)
Table 69. Key Industry Trends of Cholera Vaccine (Oral Route)
Table 70. Cholera Vaccine (Oral Route) Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Cholera Vaccine (Oral Route) Distributors List
Table 73. Cholera Vaccine (Oral Route) Customer List
Table 74. Global Cholera Vaccine (Oral Route) Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Cholera Vaccine (Oral Route) Sales Market Forecast by Region
Table 76. Global Cholera Vaccine (Oral Route) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Cholera Vaccine (Oral Route) Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Cholera Vaccine (Oral Route) Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Cholera Vaccine (Oral Route) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Cholera Vaccine (Oral Route) Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Cholera Vaccine (Oral Route) Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Cholera Vaccine (Oral Route) Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Cholera Vaccine (Oral Route) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Cholera Vaccine (Oral Route) Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Cholera Vaccine (Oral Route) Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Cholera Vaccine (Oral Route) Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Cholera Vaccine (Oral Route) Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Cholera Vaccine (Oral Route) Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Cholera Vaccine (Oral Route) Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Cholera Vaccine (Oral Route) Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Cholera Vaccine (Oral Route) Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Cholera Vaccine (Oral Route) Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Cholera Vaccine (Oral Route) Revenue Market Share Forecast by Application (2023-2028)
Table 94. PaxVax Basic Information, Cholera Vaccine (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 95. PaxVax Cholera Vaccine (Oral Route) Product Offered
Table 96. PaxVax Cholera Vaccine (Oral Route) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 97. PaxVax Main Business
Table 98. PaxVax Latest Developments
Table 99. Sanofi Basic Information, Cholera Vaccine (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Cholera Vaccine (Oral Route) Product Offered
Table 101. Sanofi Cholera Vaccine (Oral Route) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. Valneva Basic Information, Cholera Vaccine (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 105. Valneva Cholera Vaccine (Oral Route) Product Offered
Table 106. Valneva Cholera Vaccine (Oral Route) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 107. Valneva Main Business
Table 108. Valneva Latest Developments
Table 109. EuBiologics Basic Information, Cholera Vaccine (Oral Route) Manufacturing Base, Sales Area and Its Competitors
Table 110. EuBiologics Cholera Vaccine (Oral Route) Product Offered
Table 111. EuBiologics Cholera Vaccine (Oral Route) Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 112. EuBiologics Main Business
Table 113. EuBiologics Latest Developments
List of Figures
Figure 1. Picture of Cholera Vaccine (Oral Route)
Figure 2. Cholera Vaccine (Oral Route) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Cholera Vaccine (Oral Route) Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Cholera Vaccine (Oral Route) Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Cholera Vaccine (Oral Route) Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Shanchol
Figure 10. Product Picture of Dukoral
Figure 11. Product Picture of Vaxchora
Figure 12. Product Picture of Others
Figure 13. Global Cholera Vaccine (Oral Route) Sales Market Share by Type in 2021
Figure 14. Global Cholera Vaccine (Oral Route) Revenue Market Share by Type (2017-2022)
Figure 15. Cholera Vaccine (Oral Route) Consumed in Hospital
Figure 16. Global Cholera Vaccine (Oral Route) Market: Hospital (2017-2022) & (K Units)
Figure 17. Cholera Vaccine (Oral Route) Consumed in Research & Academic Laboratories
Figure 18. Global Cholera Vaccine (Oral Route) Market: Research & Academic Laboratories (2017-2022) & (K Units)
Figure 19. Cholera Vaccine (Oral Route) Consumed in Pharmaceutical & Biotechnology Companies
Figure 20. Global Cholera Vaccine (Oral Route) Market: Pharmaceutical & Biotechnology Companies (2017-2022) & (K Units)
Figure 21. Cholera Vaccine (Oral Route) Consumed in Others
Figure 22. Global Cholera Vaccine (Oral Route) Market: Others (2017-2022) & (K Units)
Figure 23. Global Cholera Vaccine (Oral Route) Sales Market Share by Application (2017-2022)
Figure 24. Global Cholera Vaccine (Oral Route) Revenue Market Share by Application in 2021
Figure 25. Cholera Vaccine (Oral Route) Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Cholera Vaccine (Oral Route) Revenue Market Share by Company in 2021
Figure 27. Global Cholera Vaccine (Oral Route) Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Cholera Vaccine (Oral Route) Revenue Market Share by Geographic Region in 2021
Figure 29. Global Cholera Vaccine (Oral Route) Sales Market Share by Region (2017-2022)
Figure 30. Global Cholera Vaccine (Oral Route) Revenue Market Share by Country/Region in 2021
Figure 31. Americas Cholera Vaccine (Oral Route) Sales 2017-2022 (K Units)
Figure 32. Americas Cholera Vaccine (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 33. APAC Cholera Vaccine (Oral Route) Sales 2017-2022 (K Units)
Figure 34. APAC Cholera Vaccine (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 35. Europe Cholera Vaccine (Oral Route) Sales 2017-2022 (K Units)
Figure 36. Europe Cholera Vaccine (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Cholera Vaccine (Oral Route) Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Cholera Vaccine (Oral Route) Revenue 2017-2022 ($ Millions)
Figure 39. Americas Cholera Vaccine (Oral Route) Sales Market Share by Country in 2021
Figure 40. Americas Cholera Vaccine (Oral Route) Revenue Market Share by Country in 2021
Figure 41. United States Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Cholera Vaccine (Oral Route) Sales Market Share by Region in 2021
Figure 46. APAC Cholera Vaccine (Oral Route) Revenue Market Share by Regions in 2021
Figure 47. China Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Cholera Vaccine (Oral Route) Sales Market Share by Country in 2021
Figure 54. Europe Cholera Vaccine (Oral Route) Revenue Market Share by Country in 2021
Figure 55. Germany Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Cholera Vaccine (Oral Route) Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Cholera Vaccine (Oral Route) Revenue Market Share by Country in 2021
Figure 62. Egypt Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Cholera Vaccine (Oral Route) Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Cholera Vaccine (Oral Route) in 2021
Figure 68. Manufacturing Process Analysis of Cholera Vaccine (Oral Route)
Figure 69. Industry Chain Structure of Cholera Vaccine (Oral Route)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
